MarketInOut Stock Screener Log In | Sign Up

Piramal Pharma Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:51
Piramal Pharma Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization253,083 mln
Float626 mln
Earnings Date10/27/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-2.97
Likely reliable

1-Year Forecast

236.45
Attractive

Relative Strength

77 / 100
Strongly outperforming

Debt / Equity

0.70
Moderate leverage

Pre-Tax Margin

-2%
Barely loss-making

Business Description

Piramal Pharma Limited is a Mumbai-based pharmaceutical company founded in 2020, with operations spanning the United States, Europe, Japan, India, and other markets worldwide. The company supports drug developers through contract services covering every stage of a medicine's life, from early research through to large-scale production. It also sells its own range of finished medicines, including anesthetics, pain treatments, and injectables, alongside consumer health products such as pain relief, skin care, digestive health, and women's wellness items.

Key Fundamentals

EPS-2.37
ROE-4.58
RPS69.24
ROIC1.10
ROA-2.22
Interest Cover0.45
EBITDA, mln10,376
EV / EBITDA31.08
EV / EBIT179
Revenue, mln92,053
EV / Revenue3.50

Quote Details

Last 198.45
Change 3.3 (1.69%)
Open 196.30
Volume 111,858
Turnover 22,198,220
Average Volume 272,362

Financial Ratios

Pre-Tax Profit Margin-2
Current Ratio1.51
Price / Book3.34
Price / Tangible Book6.80
Price / Cash Flow28.41
Price / Free Cash Flow53.93
Debt / Equity0.70
Price / Sales2.96

Financial Strength

Altman Z-Score2.43
Piotroski F-Score 2 / 9
Beneish M-Score-2.97
1-Year Target Price236.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.08% 86 / 100   
1 Month -4.66% 62 / 100   
2 Months 10.9% 83 / 100   
6 Months 19.84% 81 / 100   
1 Year 2.14% 73 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog